跳至主要内容
临床试验/KCT0005078
KCT0005078已完成未知

Effects of probiotic bacterium Weissella cibaria CMU on oral health and psychosocial health

Kangwon National University0 个研究点目标入组 68 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 60(Year)(—)
性别
All

入选标准

  • 1) The person with written consent and acceptable communication capacity
  • 2) The person with 20 years old more
  • 3) The person with 20 natural teeth more
  • 4) The person without tongue health problem (tongue cancer, tongue inflammation, etc.)
  • 5) The person with more tnan 1.5 ng/10ml of VSC (H2S, CH3SH, (CH3)2S)

排除标准

  • 1) The person with less than 80%(total intake of 44.8 tablets) compliance of study regimen (total intake of 56 tablets)
  • 2) The person without ability of communicattion in spite of aids of glasses, magnifying glass, hearing-aid
  • 3) The person with mental health problem (schizophrenia, mental retardation, etc.)
  • 4) The person with treatment of systemic health problem causing halitosis (liver disease, kidney disease, Sjögren syndrome, rheumatism, etc.)
  • 5) The person with diagnosis of rhinitis or sinus infection
  • 6) The person with taking antibiotics (correspond to taking during this study, within 2 weeks after screening, or within last 1 month)
  • 7) The person with more than 3 times of normal range of GOT and GPT
  • 8) The person with more than 2 times of normal range of BUN/Creatinine
  • 9) The person with diagnosis of chronic gastritis
  • 10) The person with uncontrollerable high blood pressure (SBP 160mmHg higher or DBP 100mmHg higher)
  • 11) The person with more than 126mg/dL of fasting blood sugar (FBS) or 200mg/dL of random glucose, or current DMpatient with taking insulin or oral hypoglycemic agent
  • 12) The person with continuous intake of oral probiotic related health medicinal products within a week after screening
  • 13) The person with sensitivity or alllergy by probiotic products including dairy product
  • 14) The person with participation to the other human application clinical trial within last 4 weeks
  • 15) The person to be thought Inappropriate in this human application study by research team's judgement
  • 16) The person with taking Warfarin or Aspirin
  • 17) The person with risk of aspiration
  • 18) The person with xerostomia
  • 19) The person with severe perodontal health problem or multiple dental carries, and 5 more dental caries with need of prompt treatment

研究者

相似试验